| abstract |
The present invention relates to the treatment of neuromuscular disorders, more particularly apomorphine, bromocriptine, pergolide, ropinirole, octahydropyrazolo [3,4-g] quinoline and trans- (±) -substituted-5,5a, 6,7. , 6,9-, 9a, 10-octahydropyrimido [4,5-g] quinoline, and pharmaceutically acceptable salts thereof for treating the symptoms of fibromyalgia syndrome and chronic fatigue syndrome. Or for use in the manufacture of a medicament for treating. |